Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance

UBC Medical Indonesia Tbk.Trade
Hetzer Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp72 (market cap 114.06B, 23.06M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 5.7× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (23.06M versus 848.2K). Which is the better fit depends on your goals.

LABSMEDS
Market Cap
651.75B114.06B
Volume
848.2K23.06M
Lot
8.48K230.55K
Turnover
140.51M1.68B
Average Price
165.6672.75
Value
140.51M1.68B
Indicative Equilibrium Price
16872
Indicative Equilibrium Volume
501.56K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MEDS
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS